Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118843813 | 11884381 | 3 | F | 20160828 | 20160103 | 20160901 | EXP | PHHY2013IL096439 | NOVARTIS | 0.00 | F | Y | 86.00000 | KG | 20160902 | CN | COUNTRY NOT SPECIFIED | IL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118843813 | 11884381 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 400 MG, BID | S0127 | 22068 | 400 | MG | CAPSULE | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118843813 | 11884381 | 1 | Chronic myeloid leukaemia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118843813 | 11884381 | Back pain | |
| 118843813 | 11884381 | Ear infection | |
| 118843813 | 11884381 | Increased appetite | |
| 118843813 | 11884381 | Pain in extremity | |
| 118843813 | 11884381 | Peripheral swelling | |
| 118843813 | 11884381 | Varicose vein |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118843813 | 11884381 | 1 | 2010 | 0 |